Fundraising Fox
/Companies
Sign in

Arcutis

NASDAQ: ARQT

Westlake Village, US · Founded 2016 · 477 employees on LinkedIn · 3 known investors

Find your way into Arcutis

Sign up to see every warm intro you have to Arcutis

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Arcutis team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Arcutis is a biopharmaceutical company focused on dermatology, developing treatments for immune-mediated skin diseases such as plaque psoriasis, atopic dermatitis, seborrheic dermatitis, and scalp psoriasis. It serves patients and healthcare professionals with therapies aimed at improving drug efficacy, safety, and tolerability.

BiotechHealthtechMedical Devices

Founders & leadership

TF
Todd Franklin WatanabeExecutive
AA
Alexander AsamNamed on SEC filing
RSRicky Sun
Ricky SunNamed on SEC filingPartner at Bain Capital Life Sciences

Board

PHPatrick Heron
Patrick HeronBoard MemberManaging Partner at Frazier Life Sciences
DEDaniel Estes
Daniel EstesBoard directorGeneral Partner at Frazier Life Sciences
JS
Jonathan SilversteinBoard director
BCBhaskar Chaudhuri
Bhaskar ChaudhuriBoard directorSenior Advisor at Frazier Life Sciences

Investors · 3

Frazier Life Scienceslisted by Frazier Life SciencesPalo Alto

How we know: Frazier Life Sciences's portfolio page · board seat on SEC Form D · Not right? Tell us

RA Capitallisted by RA CapitalBoston

How we know: RA Capital's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$94.5M disclosed across 1 round · 2019

▶$94.5MraisedOct 2019 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexander AsamDirector
  • Patrick HeronDirector
  • Daniel EstesDirector
  • Ricky SunDirector
  • Jonathan SilversteinDirector
  • Bhaskar ChaudhuriDirector
  • Todd Franklin WatanabeExecutive Officer, Director
Offering amount
$94.5M
Amount sold
$94.5M
First sale
Oct 2019
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.

Companies working in the same space as Arcutis.

Frequently asked questions

What does Arcutis do?
Arcutis is a biopharmaceutical company focused on dermatology, developing treatments for immune-mediated skin diseases such as plaque psoriasis, atopic dermatitis, seborrheic dermatitis, and scalp psoriasis. It serves patients and healthcare professionals with therapies aimed at improving drug efficacy, safety, and tolerability.
Who are Arcutis's investors?
Arcutis's investors include Bain Capital Life Sciences, Frazier Life Sciences, RA Capital.
How much funding has Arcutis raised?
Arcutis has disclosed $94.5M raised across 1 round.
Where is Arcutis headquartered?
Arcutis is headquartered in Westlake Village, US.